TrialMolecular oncology2023

Atezolizumab and stereotactic body radiotherapy in patients with advanced non-small cell lung cancer: safety, clinical activity and ctDNA responses-the ComIT-1 trial.

Henrik Horndalsveen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.